Argenx
ARGX
$989.56
Share price
-0.19%
Change (1 day)
54.41%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Argenx (ARGX) - P/B ratio
P/B ratio as of April 2025 : 6.09
According to Argenx
's latest financial reports the company has a price-to-book ratio of 15.2856.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Argenx - P/B ratio (from 2021 to 2020)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 6.81 | 23.68% |
| 2023-12-31 | 5.51 | -26.06% |
| 2022-12-31 | 7.45 | 2.64% |
| 2021-12-31 | 7.26 | 6.56% |
| 2020-12-31 | 6.81 | 30.91% |
| 2019-12-31 | 5.20 | 4.53% |
| 2018-12-31 | 4.98 | 23.24% |
| 2017-12-31 | 4.04 | |
| 2016-12-31 | N/A | |
| 2015-12-31 | N/A | -100% |
| 2014-12-31 | 1.96 | |
| 2013-12-31 | N/A |